Crucell N.V.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

Document Sample
Crucell N.V.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report Powered By Docstoc
					Crucell N.V.

_________________________________________________________________________________



Crucell N.V.                                                                    Financial Snapshot

                                                                                Operating Performance
Fast Facts
                                       Archimedesweg 4-6, Leiden, 2301          The company reported revenue of US$440 million
Headquarters Address
                                       CA,Netherlands                           during the fiscal year 2010 (2010). The company's
                                                                                revenue grew at a CAGR of 27.87% during 2006–
Telephone                               + 31 71 5199100
                                                                                2010, with an annual decline of 6.39% over 2009. In
                                                                                2010, the company recorded an operating margin of -
Fax                                     + 31 71 5199800                         10.41%, as against 11.54% in 2009.

Website                                www.crucell.com
                                                                                Revenue and Margins
Ticker Symbol, Stock Exchange          N/A

Number of Employees                    1,398

Fiscal Year End                        December

Revenue (in US$ million)               440




SWOT Analysis

Strengths                              Weaknesses

Broad product portfolio                Product recall and shipment withdrawal

Leading-edge technologies

Strategic partners

Opportunities                          Threats

Increasing infectious disease outbreaks Intense competition

Strong product development pipeline    Tightening regulations

                                       Uncertain R&D outcomes




___________________________________________________________________________________________

Crucell N.V. - SWOT Profile                                                                                          Page 1
Crucell N.V.

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset and Liabilities .........................................................................................................................................11
      2.2.3       Operational Efficiency ......................................................................................................................................12
      2.2.4       Solvency ..........................................................................................................................................................13
    2.3       Key Competitors ...................................................................................................................................................14
3     SWOT Analysis ...................................................................................................................................... 15
    3.1       SWOT Analysis - Overview ..................................................................................................................................15
    3.2       Strengths ..............................................................................................................................................................15
    3.3       Weaknesses .........................................................................................................................................................15
    3.4       Opportunities ........................................................................................................................................................16
    3.5       Threats .................................................................................................................................................................16
4     History .................................................................................................................................................... 17
5     Key Employees ...................................................................................................................................... 19
6     Key Employee Biographies................................................................................................................... 20
7     Locations and Subsidiaries .................................................................................................................. 21
    7.1       Head Office ..........................................................................................................................................................21
    7.2       Other Locations and Subsidiaries ........................................................................................................................21
8     Appendix ................................................................................................................................................ 23
    8.1       Methodology .........................................................................................................................................................23
    8.2       Ratio Definitions ...................................................................................................................................................23
    8.3       Disclaimer.............................................................................................................................................................27




___________________________________________________________________________________________

Crucell N.V. - SWOT Profile                                                                                                                                                 Page 2
Crucell N.V.

__________________________________________________________________________________________



List of Tables

Table 1: Major Products and Services....................................................................................................................................6
Table 2: Key Ratios - Annual ..................................................................................................................................................7
Table 3: Key Ratios - Interim ..................................................................................................................................................9
Table 4: History.....................................................................................................................................................................17
Table 5: Key Employees .......................................................................................................................................................19
Table 6: Key Employee Biographies ....................................................................................................................................20
Table 7: Subsidiaries ............................................................................................................................................................21
Table 8: Locations ................................................................................................................................................................21




___________________________________________________________________________________________

Crucell N.V. - SWOT Profile                                                                                                                                                Page 3
Crucell N.V.

__________________________________________________________________________________________


List of Figures

Figure 1: Revenue and Operating Profit ...............................................................................................................................10
Figure 2: Financial Position ..................................................................................................................................................11
Figure 3: Operational Efficiency ...........................................................................................................................................12
Figure 4: Solvency ................................................................................................................................................................13




___________________________________________________________________________________________

Crucell N.V. - SWOT Profile                                                                                                                                              Page 4
Crucell N.V.

__________________________________________________________________________________________




1 Business Analysis

1.1   Company Overview

Crucell N.V. (Crucell) is a biopharmaceutical company focusing on research and development, manufacturing, and
marketing of drugs for the treatment and prevention of infectious diseases. The company operates as a center for
vaccines within the Johnson & Johnson pharmaceuticals group. Crucell’s product line includes vaccines, proteins and
antibodies. The company is one of the leading suppliers of vaccines to UNICEF and the developing world. It marke
				
DOCUMENT INFO
Description: Synopsis ICD Research's "Crucell N.V.: Pharmaceuticals and Healthcare - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Crucell N.V." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope • Examines and identifies key information and issues about "Crucell N.V." for business intelligence requirements. • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported. • Provides data on company financial performance. • The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries. Reasons To Buy • Quickly enhance your understanding of "Crucell N.V." • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry. • Increase business/sales activities by understanding your competitors’ businesses better. • Recognize potential partnerships and suppliers. Key Highlights Crucell N.V. (Crucell) is a biopharmaceutical company focusing on research and development, manufacturing, and marketing of drugs for the treatment and prevention of infectious diseases. The company operates as a center for vaccines within the Johnson & Johnson pharmaceuticals group. Crucell's product line includes vaccines, proteins and antibodies.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER ICD Research
With emphasis on Insight, Consultancy and Delivery, iCD Research is a full-service, online market research agency. iCD Research is able to take advantage of all of the efficiencies and benefits that the Internet brings to offer proven research methodologies with fast turnaround and accurate results. iCD Research specialises in qualitative research for large finance, media, retail and entertainment clients. Market leaders in online focus groups, iCD Research has unleashed the full scale of the Internet to run focus groups across the globe for its major institutional clients. Utilising its sister organisation, The iD Factor, iCD Research also delivers strong quantitative research, ranging from ongoing consumer confidence studies through to consumer surveys throughout Europe and Asia. With its roots firmly in research, iCD Research doesn’t limit itself to only utilising online methods as the philosophy at the company is to match the methodology to the respondent. Yet the scale and speed of online research give iCD Research a cutting edge that has lead to tremendous, triple-figure percentage growth over the past two years. iCD Research is headquartered in London, with operational offices in the US and Australia to ensure that it is offering an unparalleled 24 hour service to its clients.